These regulations reschedule cannabis-based products for medicinal use and will come into force on 1 November 2018.
There is a high unmet need for novel, safe and natural therapies
To evaluate adherence among Israeli patients who are licensed to use medical cannabis and to identify factors associated with adherence to medical cannabis. Ninety-five novice licensed patients were interviewed for this cross-sectional study. Our findings show a relatively high adherence rate for medical cannabis, as well as relative safety and high satisfaction among licensed patients. Additionally indicated is the need to develop and implement standardized education about this evolving field-to both patients and physicians.